Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05446779

Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death

Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death Without Definitive Causative Diagnosis (PEA-SuddenDeath)

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Helsinki University Central Hospital · Academic / Other
Sex
All
Age
35 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Sudden Cardiac Death is a leading cause of mortality and remains a major public health burden worldwide. Cardiac arrest due to coronary heart disease explains a large proportion of the cases, but if autopsy is not performed the exact underlying cause remains obscure in many adults who face sudden death outside heath care organizations. The investigators aim to find proof that primary aldosteronism is a risk factor for sudden death and to characterize the prevalence of adrenal pathology in sudden death of undetermined cause in a case-control study. In addition, the study aims to characterize the prevalence of other adrenal pathology i.e. silent adenomas, cortisol-producing adenomas and pheochromocytomas in sudden death. The investigators also seek evidence that other endocrine hormone overproduction-causing diseases are more prevalent in persons with sudden death compared with those experiencing traumatic or suicidal death sudden death.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAdrenal aldosterone synthase (CYP11B2) stainingImmunoshistochemical diagnosis of primary aldosteronism
DIAGNOSTIC_TESTAdrenal cortisol synthase (CYP11B1) stainingImmunoshistochemical diagnosis of adrenal hypercortisolism
DIAGNOSTIC_TESTHistopathological analysisDiagnosis of any endocrine neoplasia other than primary aldosteronism or adrenal hypercortisolism

Timeline

Start date
2022-02-03
Primary completion
2023-01-31
Completion
2026-12-31
First posted
2022-07-07
Last updated
2024-04-16

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT05446779. Inclusion in this directory is not an endorsement.